Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Peter Jacobus Johannes Antonius Buijnsters"'
Autor:
José Manuel Bartolomé-Nebreda, Adriana Ingrid Velter, Peter Jacobus Johannes Antonius Buijnsters, Andrés A. Trabanco
Publikováno v:
Expert Opinion on Therapeutic Patents. 31:1117-1154
Introduction: O-GlcNAcylation is a highly abundant post-translational modification of multiple proteins, including the microtubule-binding protein tau, governed by just two enzymes’ concerted actio...
Autor:
Frans A. F. Van den Keybus, Peter Jacobus Johannes Antonius Buijnsters, Andrés A. Trabanco, Marijke Somers, Marieke Lamers, Gary Tresadern, Greet Vanhoof, Yves Emiel Maria Van Roosbroeck, Gregor James Macdonald, Ingrid Velter, Philip Leonard
Publikováno v:
Journal of Medicinal Chemistry. 63:12887-12910
We describe the hit-to-lead exploration of a [1,2,4]triazolo[1,5-a]pyrimidine phosphodiesterase 2A (PDE2A) inhibitor arising from high-throughput screening. X-ray crystallography enabled structure-guided design, leading to the identification of prefe
Publikováno v:
Expert opinion on therapeutic patents. 32(5)
INTRODUCTION : Ubiquitin specific peptidase 30 (USP30) is a mitochondrial deubiquitinase that antagonizes ubiquitination-mediated mitophagy of damaged or impaired mitochondria driven by the activity of PARK2/Parkin ubiquitin ligase and PINK1 protein
Autor:
Adam Arany, Jörg K. Wegner, Jorge Vialard, Vladimir Chupakhin, Marvin Steijaert, Anne E. Carpenter, Shantanu Singh, Peter Jacobus Johannes Antonius Buijnsters, Yves Moreau, Jaak Simm, Emmanuel Gustin, Ingrid Velter, Roel Wuyts, Sepp Hochreiter, A. Vapirev, Yolanda T. Chong, Hugo Ceulemans, Günter Klambauer
In both academia and the pharmaceutical industry, large-scale assays for drug discovery are expensive and often impractical, particularly for the increasingly important physiologically relevant model systems that require primary cells, organoids, who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afdc9b02e29c077539f5f8d0bd2c0b57
https://lirias.kuleuven.be/handle/123456789/628737
https://lirias.kuleuven.be/handle/123456789/628737
Autor:
Thomas Steinbrecher, José-Ignacio Andrés, Greet Vanhoof, Peter Jacobus Johannes Antonius Buijnsters, Andrés A. Trabanco, Frederik J. R. Rombouts, Xavier Langlois, Gary Tresadern, Marijke Somers, Fulgencio Tovar
Publikováno v:
ACS Medicinal Chemistry Letters. 6:282-286
A novel series of pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines is reported as potent PDE2/PDE10 inhibitors with drug-like properties. Selectivity for PDE2 was obtained by introducing a linear, lipophilic moiety on the meta-position of the phenyl ring
Autor:
Jorge Vialard, Vladimir Chupakhin, Yves Moreau, Günter Klambauer, Shantanu Singh, Marvin Steijaert, Adam Arany, Sepp Hochreiter, Anne E. Carpenter, Hugo Ceulemans, Roel Wuyts, Emmanuel Gustin, Jörg K. Wegner, Peter Jacobus Johannes Antonius Buijnsters, A. Vapirev, Ingrid Velter, Jaak Simm, Yolanda T. Chong
We repurpose a High-Throughput (cell) Imaging (HTI) screen of a glucocorticoid receptor assay to predict target protein activity in multiple other seemingly unrelated assays. In two ongoing drug discovery projects, our repurposing approach increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0059d469db8ccdab4e892970cfab25d3
Publikováno v:
Expert opinion on therapeutic patents. 26(8)
The cyclic nucleotides cAMP and cGMP are ubiquitous intracellular second messengers regulating a large variety of biological processes. The intracellular concentration of these biologically relevant molecules is modulated by the activity of phosphodi
Autor:
Andrés A. Trabanco, Meri De Angelis, Peter Jacobus Johannes Antonius Buijnsters, Wendy Sanderson, Alison Ritchie, Greet Vanhoof, Xavier Langlois, Yves Emiel Maria Van Roosbroeck, Gary Tresadern, Frederik J. R. Rombouts, José-Ignacio Andrés
Publikováno v:
ACS medicinal chemistry letters. 5(9)
Structure-guided design led to the identification of the novel, potent, and selective phosphodiesterase 2 (PDE2) inhibitor 12. Compound 12 demonstrated a >210-fold selectivity versus PDE10 and PDE11 and was inactive against all other PDE family membe
Autor:
Xavier Langlois, Frederik J. R. Rombouts, Peter Jacobus Johannes Antonius Buijnsters, Meri De Angelis, José-Ignacio Andrés, Andrés A. Trabanco, Greet Vanhoof
Publikováno v:
Bioorganicmedicinal chemistry letters. 23(3)
The synthesis, preliminary evaluation and structure–activity relationship (SAR) of a series of 1-aryl-4-methyl[1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors are described. From this inves
Autor:
Martinus C. Feiters, Nico A. J. M. Sommerdijk, Peter ten Holte, Sandy A. C. Verhaegen, Peter Jacobus Johannes Antonius Buijnsters, Arthur M.A. Pistorius, René de Gelder, Roeland J. M. Nolte, Binne Zwanenburg
Publikováno v:
Journal of Materials Chemistry, 11(2), 269-277. Royal Society of Chemistry
Journal of Materials Chemistry, 11, 269-277
Journal of Materials Chemistry, 11, pp. 269-277
Journal of Materials Chemistry, 11, 2, pp. 269-277
Journal of Materials Chemistry, 11, 269-277. Royal soc chemistry
Journal of Materials Chemistry, 11, 269-277
Journal of Materials Chemistry, 11, pp. 269-277
Journal of Materials Chemistry, 11, 2, pp. 269-277
Journal of Materials Chemistry, 11, 269-277. Royal soc chemistry
Two novel long chain aziridinemethanols ( 1b, c) are described and their molecular organisation in the bulk and self-assembling properties in aqueous dispersion are reported. The orientation of the NH hydrogen of the aziridinealcohol moiety in 1b can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d86c6402eeda10047caba2de64c4ed1
https://doi.org/10.1039/b006428i
https://doi.org/10.1039/b006428i